Nestle Health Science US Holdings Inc. 13D and 13G filings for Seres Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-07-22 1:34 pm Sale | 2022-07-18 | 13D | Seres Therapeutics, Inc. MCRB | Nestle Health Science US Holdings Inc. | 7,594,038 6.100% | -298,852 (-3.79%) | Filing |
| 2020-08-19 5:17 pm Purchase | 2020-08-17 | 13D | Seres Therapeutics, Inc. MCRB | Nestle Health Science US Holdings Inc. | 7,892,890 8.800% | 993,689 (+14.40%) | Filing |